With the massive growth in computing capacity and the connectivity that exists in the world today, medicine has changed drastically. These changes bring opportunity for more change to improve health care. Medical information is now available at our fingertips and can be acquired rapidly. As such, the massive memorizing tasks and learning skills of the past are less relevant. Robust clinical pathways are available in apps, online medical care tools, and health information systems, and in some cases are proven to improve patient care, with failure to follow them resulting in worse patient outcomes.
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1 Thirty years ago, there were only a handful of clinical prediction algorithms/models to assist physicians in decision making. Now there are hundreds. Despite this, the uptake of algorithms in clinical practice has been slow, sporadic, and fraught with skepticism. 2 This uptake, or lack thereof, has been justified by arguments that predictive algorithms were developed in populations of patients that were not necessarily applicable to "the patient in front of me." In other words, studies were not generalizable. Yet physicians have become all too quick to order diagnostic tests without following algorithms or predictive tools under the assumption that this is best, and ignoring the possibility of harm, including radiation exposure, false-positive tests, and the economic burden on society.
It is estimated that 5% of the US gross domestic product is spent on diagnostic tests and procedures that do not result in any improvement in patient outcomes. In conclusion, I encourage physicians to have an open mind about artificial intelligence and deep machine learning, and to embrace the application and use of predictive algorithms that undoubtedly will unfold over the next decade. This is one of the key pathways to cost-effective, efficient, and safe health care. We should overcome fear of the black box concept of articifial intelligence, and physicians need to trust that large, well-managed data sets can produce tools that will improve patient care. We must always guard against the all-too-easy default position of practicing anecdotal medicine. It is human nature to do such, but it does not improve patient care, especially from a societal perspective.
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